Literature DB >> 15008844

Street drug use among young patients with Type 1 diabetes in the UK.

R S H Ng1, D A Darko, R M Hillson.   

Abstract

BACKGROUND: Diabetic ketoacidosis (DKA) and poor glycaemic control in young adults with Type 1 diabetes may be associated with street drug use. There are few studies in the UK looking at the prevalence of drug use in young adults with diabetes.
METHODS: One hundred and fifty-eight young adults, aged sixteen to thirty years, with Type 1 diabetes attending an urban diabetes clinic were sent an anonymous confidential postal questionnaire to determine the prevalence of street drug use.
RESULTS: We received 85 completed responses. Twenty-nine percent of respondents admitted to using street drugs. Of those, 68 percent habitually took street drugs more than once a month. Seventy-two percent of users were unaware of the adverse effects on diabetes.
INTERPRETATION: Self-reported street drug usage in young adults with Type 1 diabetes is common and may contribute to poor glycaemic control and serious complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15008844     DOI: 10.1046/j.1464-5491.2003.01092.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  15 in total

Review 1.  Risky business: risk behaviors in adolescents with type 1 diabetes.

Authors:  Sarah S Jaser; Heather Yates; Susan Dumser; Robin Whittemore
Journal:  Diabetes Educ       Date:  2011-10-14       Impact factor: 2.140

Review 2.  Transition of care for patients with type 1 diabetes mellitus from pediatric to adult health care systems.

Authors:  Elizabeth O Buschur; Bethany Glick; Manmohan K Kamboj
Journal:  Transl Pediatr       Date:  2017-10

3.  Both nicotine reward and withdrawal are enhanced in a rodent model of diabetes.

Authors:  Joseph A Pipkin; Bryan Cruz; Rodolfo J Flores; Cecilia A Hinojosa; Luis M Carcoba; Melissa Ibarra; Wendy Francis; Arbi Nazarian; Laura E O'Dell
Journal:  Psychopharmacology (Berl)       Date:  2017-03-24       Impact factor: 4.530

4.  Cannabis masks diabetic ketoacidosis.

Authors:  Annemarie Hennessy
Journal:  BMJ Case Rep       Date:  2011-10-04

5.  Diabetic ketoacidosis complicated by the use of ecstasy: a case report.

Authors:  Mirnaluci Paulino Ribeiro Gama; Bárbara Vicente de Souza; Ana Carolina Ossowski; Rafaela Cristina Perraro
Journal:  J Med Case Rep       Date:  2010-08-03

6.  Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.

Authors:  Cindy Bednasz; Amneris E Luque; Barry S Zingman; Margaret A Fischl; Barbara M Gripshover; Charles S Venuto; Jie Gu; Zekun Feng; Robin DiFrancesco; Gene D Morse; Qing Ma
Journal:  Curr Vasc Pharmacol       Date:  2016       Impact factor: 2.719

Review 7.  Medical Comorbidity and Complications.

Authors:  Scott E Hadland; Leslie Renee Walker
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2016-04-12

8.  The impact of race on metabolic disease risk factors in women with and without posttraumatic stress disorder.

Authors:  Eric A Dedert; Leia A Harper; Patrick S Calhoun; Michelle F Dennis; Jean C Beckham
Journal:  J Clin Psychol Med Settings       Date:  2013-03

9.  Prevalence of alcohol, tobacco, cannabis and other illicit substance use in a population of Canadian adolescents with type 1 diabetes compared to a general adolescent population.

Authors:  Kathryn Potter; Paola Luca; Danièle Pacaud; Heidi Virtanen; Alberto Nettel-Aguirre; Laura Kaminsky; Josephine Ho
Journal:  Paediatr Child Health       Date:  2017-11-23       Impact factor: 2.253

10.  Patient attributes warranting consideration in clinical practice guidelines, health workforce planning and policy.

Authors:  Matthew J Leach; Leonie Segal
Journal:  BMC Health Serv Res       Date:  2011-09-19       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.